CH

Cowen Healthcare Investments

North America, New York, United States, New York

Description

Cowen Healthcare Investments is a financial services firm that provides alternative asset management, investment banking.

Investor Profile

Cowen Healthcare Investments has made 60 investments, with 2 in the past 12 months and 27% as lead.

Stage Focus

  • Series B (43%)
  • Series C (25%)
  • Series A (10%)
  • Post Ipo Equity (8%)
  • Series Unknown (8%)
  • Private Equity (3%)
  • Series D (2%)

Country Focus

  • United States (77%)
  • United Kingdom (12%)
  • Switzerland (8%)
  • The Netherlands (2%)
  • Canada (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Health Diagnostics
  • Oncology
  • Life Science
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cowen Healthcare Investments frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 18
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 12
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 7
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 8
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 9
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 7
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 11
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 7
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 12
Invus
North America, New York, United States, New York
Co-Investments: 7

Which angels does Cowen Healthcare Investments often collaborate with?

George Godula
Asia, Shanghai, China, Shanghai
Shared Deals: 1

What are some of recent deals done by Cowen Healthcare Investments?

Nuvig Therapeutics

Redwood City, California, United States

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

BiotechnologyHealth CareTherapeutics
Series BDec 5, 2024
Amount Raised: $161,000,000
Lycia Therapeutics

South San Francisco, California, United States

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

BiotechnologyHealth CareLife Science
Series CMay 13, 2024
Amount Raised: $106,600,000
Aro Biotherapeutics

Philadelphia, Pennsylvania, United States

Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series BNov 28, 2023
Amount Raised: $41,500,000
MBrace Therapeutics

San Diego, California, United States

MBrace Therapeutics is a privately held biopharmaceutical business.

Biotechnology
Series BNov 14, 2023
Amount Raised: $85,000,000
MapLight Therapeutics

Palo Alto, California, United States

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

BiopharmaBiotechnologyLife ScienceMedical
Series COct 30, 2023
Amount Raised: $225,000,000
Tourmaline Bio

New York, New York, United States

Tourmaline Bio is a clinical biotechnology company developing transformative medicines to dramatically improve and prevent immune diseases.

BiotechnologyClinical TrialsTherapeutics
Post Ipo EquityOct 19, 2023
Amount Raised: $75,000,000
Star Therapeutics

South San Francisco, California, United States

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

Health CareMedicalTherapeutics
Series CSep 5, 2023
Amount Raised: $90,000,000
TORL BioTherapeutics

Culver City, California, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

BiopharmaBiotechnologyClinical Trials
Series BApr 13, 2023
Amount Raised: $158,000,000
Orchard Therapeutics

London, England, United Kingdom

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Post Ipo EquityMar 6, 2023
Amount Raised: $34,000,000
Escient Pharmaceuticals

San Diego, California, United States

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series CNov 28, 2022
Amount Raised: $120,000,000